期刊文献+

老年住院患者万古霉素用药情况分析 被引量:12

Analysis of the application of vancomycin in elderly inpatients
原文传递
导出
摘要 目的:调查万古霉素在老年住院患者中的应用情况。方法收集1011年9月至1013年11月在北京大学第一医院、卫生部北京医院、首都医科大学附属北京朝阳医院、首都医科大学宣武医院、解放军总医院等5家医院住院期间应用过万古霉素、年龄≥60岁且病历资料完整者的临床资料,将患者分为肾功能正常与肾功能不全1组,主要就万古霉素用药情况(给药方案、药物利用情况和血药浓度监测)、临床疗效以及药物对患者肾功能影响等进行回顾性分析。药物利用情况以药物利用指数(DUI)反映;肾功能检测指标为血清肌酐(Scr)、尿素氮(BUN)和内生肌酐清除率(Ccr)。结果共149例患者纳入分析,男性60例,女性89例;年龄60~91(76±7)岁。肾功能正常组87例,肾功能不全组61例。万古霉素给药方案肾功能正常组应用最多者为0.50 g,1次/11 h (19/87,33.33%);肾功能不全组为0.50 g,1次/d(30/61,48.39%)。万古霉素总用药量为1135.15 g,总用药时间为1919.5 d,DUI 为0.56。149例患者中进行血药浓度监测者111例(74.50%),肾功能正常组与肾功能不全组行血药浓度监测者占比差异无统计学意义[70.11%(61/87)比80.65%(50/61),χ1=1.113,P=0.146]。行血药浓度监测者均监测了万古霉素谷浓度,监测峰浓度者7例。万古霉素谷浓度以﹤10 mg/L者占比最大,肾功能正常组和肾功能不全组分别为30例(49.18%)和15例(50.00%)。各组间数据差异均无统计学意义(χ1=1.16,P =0.54)。149例患者用药前后Scr[(117±79)μmol/L比(119±81)μmol/L]、BUN[(10.5±5.7)mmol/L比(11.5±8.0)mmol/L]和Ccr[(69±37)ml/min比(67±36)ml/min]比较,差异均无统计学意义(均P﹥0.05)。肾功能正常组和肾功能不全组患者用药前后 Scr[(59±16)μmol/比(70±30)μmol/L,(189±110)μmol/L 比(103±113)μmol/L]、BUN[(7.4±3.5� Objective To investigate the application of vancomycin in elderly inpatients. Methods The clinical data of elderly inpatients(≥60 years ) treated with vancomycin from September 1011 to November 1013 in 5 hospitals including Peking University First Hospital,Beijing Hospital,Beijing Chao-Yang Hospital,Xuanwu Hospital of Capital Medical University,and Chinese PLA General Hospital were collected. All patients were divided into normal renal function group and renal insufficiency group. The application( dosage regimen,drug utilization situation,and therapeutic drug monitoring ) and clinical efficacy of vancomycin and its effects on renal function in elderly patients were retrospectively analyzed. Drug utilization index( DUI)reflected the drug utilization situation. And parameters of renal function included serum creatinine(Scr),blood urea nitrogen(BUN)and creatinine clearance rate(Ccr). Results A total of 149 patients were enrolled in this study comprising 60 males and 89 females with age of 60-91(76 ± 7)years. There were 87 cases in the normal renal function group and 61 cases in renal insufficiency group. The most widely used regimen of application of vancomycin was 0. 50 g once every 11 hours in the normal renal function group(19/87,33. 33%)and 0. 50 g once daily in the renal insufficiency group(30/61, 48. 39%). The total dosage and time of using vancomycin were respectively 1 135. 15 g and 1 919. 5 d. And the DUI was 0. 56. Among the 149 patients,111 cases(74. 50%)underwent blood concentration monitoring and there were no statistically significant differences in constituent ratio of undergoing blood concentration monitoring between the normal renal function group and the renal insufficiency group[70. 11%(61/87)vs. 80. 65%(50/61),χ1 =1. 11,P=0. 15]. In all patients undergoing blood concentration monitoring,trough concentration was detected and in 7 patients peak concentration was detected. The number of cases whose trough concentrations ﹤10 mg/L was 30
出处 《药物不良反应杂志》 CSCD 2014年第4期193-197,共5页 Adverse Drug Reactions Journal
基金 卫生部行业基金老年专项课题(201002011)
关键词 万古霉素 老年人 血药浓度 肾功能不全 Vancomycin Aged Plasma concentration Renal insufficiency
  • 相关文献

参考文献6

二级参考文献44

  • 1李家泰,魏瑾.甲氧西林耐药金葡菌(MRSA)感染的诊断与治疗[J].中国临床药理学杂志,1993,9(2):97-108. 被引量:24
  • 2医院感染诊断标准[s].北京:中华人民共和国卫生部,2001:1-35. 被引量:6
  • 3王海燕,王梅.慢性肾脏病及透析的临床实践指南(附评述)[M].北京:人民卫生出版社,2003:1-301. 被引量:8
  • 4K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative[ J]. Am J Kidney Dis ,2002,39( Suppl 2 ) :S1 - S246. 被引量:1
  • 5The Diabetes Control and Complications Trail Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[ J]. N Engl J Med ,1993 ,329 :977 -986. 被引量:1
  • 6Klahr S, Levey AS, Greene T, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group [J]. N Engl J Med,1994,330:844 -877. 被引量:1
  • 7汪复,张婴元.实用抗感染治疗学[M].北京:人民卫生出版社,2005:134. 被引量:66
  • 8Boh LE.药学临床实践指南[M].陆进,常明,译.北京:化学工业出版社,2007:223-224. 被引量:2
  • 9Jesus Valle M J, Lopez FG, Navarro AS. Development and validation of an HPLC method for vancomyein and its application to a pharmacokinetic study[J]. J Pharm Biomed Anal, 2008, 48(3): 835-839. 被引量:1
  • 10Lee P, Dipersio D, Jerome RN, et al. Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics[J]: J Med Libr Assoc, 2007, 95(4): 374-380. 被引量:1

共引文献948

同被引文献68

引证文献12

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部